在局部软组织肉瘤中进行化疗的综合性审查:猫已经出来了吗?
Anand Mohan1, Abhay K Kattepur2, Shraddha Patkar3
1Department of Surgical Oncology, Mahatma Gandhi Medical College, Jaipur, India.
Indian journal of surgical oncology
|December 19, 2025
概括
本综述考察了化疗的使用情况.
科学领域:
- 整形瘤学 整形瘤学
- 医学瘤学 医学瘤学
- 辐射瘤学 辐射瘤学
背景情况:
- 肢体瘤是一种罕见的癌症,具有多样化的组织结构,使治疗复杂化.
- 手术和放射治疗已经成为治疗肉瘤的全球标准.
研究的目的:
- 审查化疗在局部 extremity 软组织肉瘤中的作用.
- 评估化疗在新辅助和辅助环境中的使用.
- 为了评估化学疗法与放射疗法相结合.
主要方法:
- 在四肢肉瘤治疗中化学疗法的文献综述.
- 对新辅助和辅助化疗方案的分析.
- 综合治疗方式的评估.
主要成果:
- 化疗在特定的四肢肉瘤情况下起作用.
- 新辅助和辅助化疗可以影响结果.
- 组合疗法需要仔细考虑.
结论:
- 化疗是管理四肢肉瘤的一个有价值的工具.
- 它的具体作用取决于肉瘤的亚型和阶段.
- 需要进一步的研究来优化其使用.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


